Nektar Therapeutics (NKTR) Asset Utilization Ratio (2011 - 2026)

Nektar Therapeutics' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.11 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 65.78% year-over-year to 0.11; the TTM figure through Mar 2026 stood at 0.11 (down 65.78% YoY), while the FY2025 annual figure was 0.19, down 32.59% from the prior year.
• Asset Utilization Ratio was 0.11 for Q1 2026 at Nektar Therapeutics, down from 0.19 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.32 in Q2 2025 to a low of 0.1 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.2 across 5 years, with a median of 0.19 in 2025.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio jumped 73.79% in 2023, then tumbled 65.78% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.12 in 2022, then surged by 73.79% to 0.21 in 2023, then jumped by 50.0% to 0.32 in 2024, then sank by 40.99% to 0.19 in 2025, then sank by 43.85% to 0.11 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.11 (Q1 2026), 0.19 (Q4 2025), and 0.25 (Q3 2025), per Business Quant data.